Prevention of cardiac hypertrophy in mice by calcineurin inhibition - PubMed (original) (raw)

Prevention of cardiac hypertrophy in mice by calcineurin inhibition

M A Sussman et al. Science. 1998.

Abstract

Hypertrophic cardiomyopathy (HCM) is an inherited form of heart disease that affects 1 in 500 individuals. Here it is shown that calcineurin, a calcium-regulated phosphatase, plays a critical role in the pathogenesis of HCM. Administration of the calcineurin inhibitors cyclosporin and FK506 prevented disease in mice that were genetically predisposed to develop HCM as a result of aberrant expression of tropomodulin, myosin light chain-2, or fetal beta-tropomyosin in the heart. Cyclosporin had a similar effect in a rat model of pressure-overload hypertrophy. These results suggest that calcineurin inhibitors merit investigation as potential therapeutics for certain forms of human heart disease.

PubMed Disclaimer

Comment in

• Science. 1998 Nov 6;282(5391):1007

Similar articles

• Hypertrophic defect unmasked by calcineurin expression in asymptomatic tropomodulin overexpressing transgenic mice.
  Sussman MA, Welch S, Walker A, Klevitsky R, Hewett TE, Witt SA, Kimball TR, Price R, Lim HW, Molkentin JD. Sussman MA, et al. Cardiovasc Res. 2000 Apr;46(1):90-101. doi: 10.1016/s0008-6363(99)00422-8. Cardiovasc Res. 2000. PMID: 10727657
• Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy.
  Takeda Y, Yoneda T, Demura M, Usukura M, Mabuchi H. Takeda Y, et al. Circulation. 2002 Feb 12;105(6):677-9. doi: 10.1161/hc0602.104675. Circulation. 2002. PMID: 11839620
• Reversal of cardiac hypertrophy in transgenic disease models by calcineurin inhibition.
  Lim HW, De Windt LJ, Mante J, Kimball TR, Witt SA, Sussman MA, Molkentin JD. Lim HW, et al. J Mol Cell Cardiol. 2000 Apr;32(4):697-709. doi: 10.1006/jmcc.2000.1113. J Mol Cell Cardiol. 2000. PMID: 10756124
• Calcineurin and beyond: cardiac hypertrophic signaling.
  Molkentin JD. Molkentin JD. Circ Res. 2000 Oct 27;87(9):731-8. doi: 10.1161/01.res.87.9.731. Circ Res. 2000. PMID: 11055975 Review.
• The molecular genetics of hypertrophic cardiomyopathy: prognostic implications.
  Sorajja P, Elliott PM, McKenna WJ. Sorajja P, et al. Europace. 2000 Jan;2(1):4-14. doi: 10.1053/eupc.1999.0067. Europace. 2000. PMID: 11225594 Review. No abstract available.

Cited by

• Calcineurin-NFAT dynamics correspond to cardiac remodeling during aortic banding and debanding, mimicking aortic valve replacement.
  Lunde IG, Skrbic B, Sjaastad I, Christensen G, Carlson CR, Tønnessen T. Lunde IG, et al. Front Mol Med. 2022 Oct 25;2:980717. doi: 10.3389/fmmed.2022.980717. eCollection 2022. Front Mol Med. 2022. PMID: 39086965 Free PMC article.
• The potential roles of exosomes in pathological cardiomyocyte hypertrophy mechanisms and therapy: A review.
  Zhang L, Xie F, Zhang F, Lu B. Zhang L, et al. Medicine (Baltimore). 2024 Apr 26;103(17):e37994. doi: 10.1097/MD.0000000000037994. Medicine (Baltimore). 2024. PMID: 38669371 Free PMC article. Review.
• Stage-specific therapy for hypertrophic cardiomyopathy.
  Argirò A, Zampieri M, Marchi A, Cappelli F, Del Franco A, Mazzoni C, Cecchi F, Olivotto I. Argirò A, et al. Eur Heart J Suppl. 2023 Apr 26;25(Suppl C):C155-C161. doi: 10.1093/eurheartjsupp/suad042. eCollection 2023 May. Eur Heart J Suppl. 2023. PMID: 37125313 Free PMC article.
• Cardiovascular effects of immunosuppression agents.
  Elezaby A, Dexheimer R, Sallam K. Elezaby A, et al. Front Cardiovasc Med. 2022 Sep 21;9:981838. doi: 10.3389/fcvm.2022.981838. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36211586 Free PMC article. Review.
• Protein Kinase D1 Regulates Cardiac Hypertrophy, Potassium Channel Remodeling, and Arrhythmias in Heart Failure.
  Bossuyt J, Borst JM, Verberckmoes M, Bailey LRJ, Bers DM, Hegyi B. Bossuyt J, et al. J Am Heart Assoc. 2022 Oct 4;11(19):e027573. doi: 10.1161/JAHA.122.027573. Epub 2022 Sep 29. J Am Heart Assoc. 2022. PMID: 36172952 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)